Liver Neoplasms

"Liver Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the LIVER.

Descriptor ID	D008113
MeSH Number(s)	C04.588.274.623 C06.301.623 C06.552.697
Concept/Terms	Liver Neoplasms Liver Neoplasms Neoplasms, Hepatic Neoplasms, Liver Liver Neoplasm Neoplasm, Liver Hepatic Neoplasms Hepatic Neoplasm Neoplasm, Hepatic Cancer of Liver Cancer of Liver Hepatocellular Cancer Cancers, Hepatocellular Hepatocellular Cancers Hepatic Cancer Cancer, Hepatic Cancers, Hepatic Hepatic Cancers Liver Cancer Cancer, Liver Cancers, Liver Liver Cancers Cancer of the Liver Cancer, Hepatocellular

Below are MeSH descriptors whose meaning is more general than "Liver Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Digestive System Neoplasms [C04.588.274]
Liver Neoplasms [C04.588.274.623]
Digestive System Diseases [C06]
Digestive System Neoplasms [C06.301]
Liver Neoplasms [C06.301.623]
Liver Diseases [C06.552]
Liver Neoplasms [C06.552.697]

Below are MeSH descriptors whose meaning is more specific than "Liver Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Liver Neoplasms" by people in this website by year, and whether "Liver Neoplasms" was a major or minor topic of these publications.

Bar chart showing 1907 publications over 31 distinct years, with a maximum of 117 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	5	5	10
1993	6	7	13
1994	7	6	13
1995	11	11	22
1996	13	7	20
1997	7	7	14
1998	18	5	23
1999	14	8	22
2000	21	6	27
2001	19	5	24
2002	37	15	52
2003	45	12	57
2004	45	16	61
2005	49	23	72
2006	57	12	69
2007	60	14	74
2008	75	7	82
2009	62	15	77
2010	68	16	84
2011	69	13	82
2012	61	8	69
2013	91	12	103
2014	64	9	73
2015	70	10	80
2016	92	18	110
2017	95	10	105
2018	89	13	102
2019	93	10	103
2020	109	8	117
2021	97	4	101
2022	45	1	46

Below are the most recent publications written about "Liver Neoplasms" by people in Profiles.

Woodfield SE, Mistretta BJ, Patel RH, Ibarra AM, Fisher KE, Sarabia SF, Gandhi I, Reuther J, Starosolski Z, Badachhape A, Epps J, Zorman B, Shah AP, Larson SR, Srivastava RK, Shi Y, Espinoza AF, Govindu SR, Whitlock RS, Holloway K, Roy A, Sumazin P, Ghaghada KB, Lopez-Terrada D, Gunaratne PH, Vasudevan SA. HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9).

View in: PubMed
Kelley RK, Rimassa L, Cheng AL, Kaseb A, Qin S, Zhu AX, Chan SL, Melkadze T, Sukeepaisarnjaroen W, Breder V, Verset G, Gane E, Borbath I, Rangel JDG, Ryoo BY, Makharadze T, Merle P, Benzaghou F, Banerjee K, Hazra S, Fawcett J, Yau T. Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2022 08; 23(8):995-1008.

View in: PubMed
Parikh ND, Tayob N, Al-Jarrah T, Kramer J, Melcher J, Smith D, Marquardt P, Liu PH, Tang R, Kanwal F, Singal AG. Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort. JAMA Netw Open. 2022 07 01; 5(7):e2223504.

View in: PubMed
Oluyomi AO, Mohammadi KA, El-Serag HB, Thrift AP. Mediating Effects of Neighborhood-Level Socioeconomic Deprivation on the Association Between Race/Ethnicity and Advanced Hepatocellular Carcinoma. Cancer Epidemiol Biomarkers Prev. 2022 07 01; 31(7):1402-1409.

View in: PubMed
Katabathina VS, Khanna L, Surabhi VR, Minervini M, Shanbhogue K, Dasyam AK, Prasad SR. Morphomolecular Classification Update on Hepatocellular Adenoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma. Radiographics. 2022 Sep-Oct; 42(5):1338-1357.

View in: PubMed
Shiha G, Soliman R, Mikhail NNH, Carrat F, Azzi J, Nathalie GC, Toyoda H, Uojima H, Nozaki A, Takaguchi K, Hiraoka A, Atsukawa M, Abe H, Matsuura K, Mikami S, Watanabe T, Tsuji K, Ishikawa T, Suri V, Osinusi A, Ni L, Zou J, Sarin SK, Kumar M, Jalal PK, Hashim MA, Hassan M, Lopez SA, Bañares R, Ahumada AM, Mousa NH, Eslam M, Waked I. International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients. J Viral Hepat. 2022 Sep; 29(9):807-816.

View in: PubMed
Zhu AX, Abbas AR, de Galarreta MR, Guan Y, Lu S, Koeppen H, Zhang W, Hsu CH, He AR, Ryoo BY, Yau T, Kaseb AO, Burgoyne AM, Dayyani F, Spahn J, Verret W, Finn RS, Toh HC, Lujambio A, Wang Y. Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma. Nat Med. 2022 08; 28(8):1599-1611.

View in: PubMed
Abdelrahim M, Esmail A, Umoru G, Westhart K, Abudayyeh A, Saharia A, Ghobrial RM. Immunotherapy as a Neoadjuvant Therapy for a Patient with Hepatocellular Carcinoma in the Pretransplant Setting: A Case Report. Curr Oncol. 2022 06 15; 29(6):4267-4273.

View in: PubMed
Vasudevan SA, Meyers RL, Finegold MJ, López-Terrada D, Ranganathan S, Dunn SP, Langham MR, McGahren ED, Tiao GM, Weldon CB, Malogolowkin MH, Krailo MD, Piao J, Randazzo J, Towbin AJ, BethMcCarville M, O'Neill AF, Furman WL, Rodriguez-Galindo C, Katzenstein HM. Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731. J Pediatr Surg. 2022 Oct; 57(10):251-256.

View in: PubMed
Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 2022 07 05; 34(7):969-977.e2.

View in: PubMed

People

Explore

Similar Concepts

Top Journals